Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck announces results from phase 2 trial of V114 in infants
Image: Merck announced results from a Phase 2 trial evaluating the safety, tolerability and immunogenicity of V114. Photo: Courtesy of LuAnn Hunt from Pixabay.
Image: Merck announced results from a Phase 2 trial evaluating the safety, tolerability and immunogenicity of V114. Photo: Courtesy of LuAnn Hunt from Pixabay.